A0A1U9X785 (A0A1U9X785_HUMAN) Homo sapiens (Human)

AGER UniProtKBInterProInteractive Modelling

404 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q15109

Available Structures

31 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of the human RAGE ectodomain (VC1C2 fragment) in complex with human S100A6 Heteromer
P06703; Q15109;
23-322
10014×ZN; 10×CL;ACT;CA;
Crystal structure of the human RAGE ectodomain (fragment VC1C2) in complex with mouse S100A6 Heteromer
P14069; Q15109;
23-321
100ZN;CL;ACT;CA;
The RAGE and HMGB1 complex Heteromer
P09429; Q15109;
23-233
100
Structure of CEL-PEP-RAGE V domain complex Heteromer
P02769; Q15109;
23-125
100
Structural Insights into Calcium Bound S100P - V Domain of the receptor for advanced glycation end … Heteromer
P25815; Q15109;
23-121
100
Interaction of Human S100A6 (C3S) with V domain of Receptor for Advanced Glycation End products (RA… Heteromer
P06703; Q15109;
23-121
100
RAGEC2-S100A13 tetrameric complex Heteromer
Q15109; Q99584;
235-327
100
X-ray structure of Ca(2+)-S100B with human RAGE-derived W72 peptide Heteromer
P04271; Q15109;
70-79
100CA;GOL;
X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide Heteromer
P04271; Q15109;
57-65
100CA;
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)…homo-4-mer23-231
10014×ACT;CL;V74;
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy…homo-4-mer23-231
100ACT;CL;V6Y;
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 5homo-4-mer23-231
10018×ACT;CL; 14×V6V;
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 1homo-4-mer23-231
10014×ACT;CL;V6M;
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11homo-4-mer23-231
100.012×ACT;V6M;V6P;CL;
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11homo-4-mer23-231
100.014×ACT;CL;V6P;
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.homo-2-mer23-235
100
RAGE recognizes nucleic acids and promotes inflammatory responses to DNAhomo-2-mer23-235
100EDO;
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy…homo-2-mer23-231
100ACT;CL;Y6S;
Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)…homo-2-mer23-231
100.0Y6P;ACT;CL;
Crystal structure of human rage ligand-binding domainmonomer23-240
100ACT;ZN;
Refinement of RAGE-DNA complex in 3S59 without DNAmonomer23-233
100
Refinement of RAGE-DNA complex in 3S58 without DNAmonomer23-233
100
Crystal structure of the full-length human RAGE extracellular domain (VC1C2 fragment)monomer23-233
100
Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE)monomer23-231
100GLC;SO4;
Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13monomer23-231
100ACT;V6S;V6M;
Crystal structure of the human RAGE VC1 fragment in space group P62monomer23-231
100NA;
Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal Derived A…monomer23-125
100IOR;
Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproductsmonomer23-121
100
Solution structure of the third ig-like domain from human Advanced glycosylation end product-specif…monomer235-323
100
Structure of the C-terminal Domain of RAGE and Its Inhibitormonomer362-377
93.75RQV;
Solution Structure of C-terminal RAGE (ctRAGE)monomer362-376
93.33

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4p2y.2.Amonomer0.8023-321
100.00
4lp5.2.Amonomer0.7723-321
100.00
8i9m.1.Bmonomer0.5323-230
100.00